Fibrosis News and Research

RSS

Fibrosis is the growth of fibrous tissue.

Can COVID-19 affect erectile function?

Researchers discuss the underlying mechanisms through which COVID-19 can affect erectile function.

24 Nov 2021

Human lung airway-on-a-chip faithfully recapitulates cystic fibrosis pathology

The inherited progressive disorder cystic fibrosis (CF) causes severe damage to the lungs, and other tissues in the body by affecting the cells that produce mucus, sweat, and digestive juices.

21 Nov 2021

Weill Cornell Medicine receives $1.27 million DoD grant to develop treatment for rare eye condition

Weill Cornell Medicine has received a $1.27 million grant from the United States Department of Defense (DoD) to develop treatment for a rare but devastating eye condition largely affecting military personnel who suffer traumatic eye injuries in combat.

20 Nov 2021

Researchers provide a clearer picture of healthy development of the lungs

Researchers have compiled the most comprehensive road map of the protein composition of human lungs, providing a clearer picture of the healthy development of this essential organ that made terrestrial life possible.

18 Nov 2021

Researchers receive $22 million grant for clinical trial that aims to reduce lung transplant rejection

Physicians at Washington University School of Medicine in St. Louis and Massachusetts General Hospital/Harvard Medical School in Boston have received a seven-year, $22 million grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health to help lead a multicenter clinical trial evaluating whether a novel immunosuppressant can reduce the risk of organ rejection after a lung transplant.

18 Nov 2021

The antiviral function of BET protein against SARS-CoV-2 infection

Considering the past shreds of evidence on BRD2 and BRD4 associated with viral infections, researchers have recently evaluated the function of all relevant BET proteins during COVID-19 infection.

17 Nov 2021

Lung autopsies provide a clearer picture of how SARS-CoV-2 virus spreads and causes damage

Lung autopsy and plasma samples from people who died of COVID-19 have provided a clearer picture of how the SARS-CoV-2 virus spreads and damages lung tissue.

17 Nov 2021

3D cell culturing platform allows study of idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a deadly and rapidly progressing disease with no cure. The disease involves abnormal interactions between lung cells, including fibroblasts, and their surrounding environment.

16 Nov 2021

Drug improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy

Valsartan, an angiotensin II receptor blocker drug, delayed disease progression and improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to results from a recent clinical trial published in Nature Medicine.

16 Nov 2021

Discovery of new receptor that interacts with SARS-CoV-2 spike, suppresses infection

Researchers recently conducted a study to identify host factors affecting cellular interactions of the SARS-CoV-2 spike protein.

16 Nov 2021

Updated mapping of the human genetic architecture of COVID-19

In the present study, researchers presented extensive meta-analysis and added ten new genome-wide significant loci.

15 Nov 2021

Your out-of-pocket health care costs need not be a mystery

If you've ever had a serious illness or cared for someone who has, you know how quickly the medical bills can pile up: from labs, radiology clinics, pharmacies, doctors, different departments within the same hospital — some of them in your insurance network, others not.

15 Nov 2021

Macrophages located in the cardiac tissue protect the failing heart

According to the Centers for Disease Control and Prevention, heart failure affects more than 6 million Americans and is the main cause of death for one in eight patients.

12 Nov 2021

Study may pave the way for a more personalized approach to COVID-19 diagnosis and treatment

Using some of the most advanced molecular sequencing tools available to evaluate COVID-19 rapid autopsy tissues, researchers have identified four major regulatory pathways, specific molecular effectors behind COVID-19 symptoms, and differences that drive diverging clinical courses among individual patients.

11 Nov 2021

New treatment for myocardial infarction using mussel adhesive proteins

Patients not only have to fight their diseases but also must deal with the pain – the more severe the condition, the more painful the injections.

11 Nov 2021

Platelet inhibitors may be linked with reduction in digital ulcers in people with systemic sclerosis

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that use of platelet inhibitors could be associated with a reduction in the occurrence of digital ulcers, painful sores on the extremities that can progress to gangrene, in people with systemic sclerosis.

1 Nov 2021

Hassenfeld Children's Hospital at NYU Langone performs first-ever pediatric lung transplant

Surgeons at Hassenfeld Children's Hospital at NYU Langone and the NYU Langone Transplant Institute reached a historic milestone when they used a lung transplant to treat a 16-year-old girl with cystic fibrosis whose organs were irreversibly damaged.

1 Nov 2021

Therapeutic heparin for preventing COVID-19 deaths is four times higher than the prophylactic dose

The anti-coagulant heparin reduces the likelihood of death from COVID-19 by 78% when administered in therapeutic doses to patients with signs of respiratory failure on admission to hospital, according to a study reported on October 14 in the British Medical Journal.

30 Oct 2021

Pathway preferential estrogens may be a safer alternative to hormone replacement therapy, study shows

Postmenopausal women have increased risk of non-alcoholic fatty liver disease due to loss of estrogen from metabolic changes. A high-fat diet further exacerbates the disease, which can progress to cirrhosis and liver failure.

29 Oct 2021

Five-day course of preoperative radiation therapy for sarcoma provides excellent local control rates

In a phase 2 single-institution study, UCLA Jonsson Comprehensive Cancer Center researchers found that dose-equivalent preoperative radiation therapy for extremity/trunk soft tissue sarcoma delivered in five days rather than over the conventional five weeks produced similar benefits and treatment side effects.

28 Oct 2021

Fibrosis News and Research

Further Reading

Can COVID-19 affect erectile function?

Human lung airway-on-a-chip faithfully recapitulates cystic fibrosis pathology

Weill Cornell Medicine receives $1.27 million DoD grant to develop treatment for rare eye condition

Researchers provide a clearer picture of healthy development of the lungs

Researchers receive $22 million grant for clinical trial that aims to reduce lung transplant rejection

The antiviral function of BET protein against SARS-CoV-2 infection

Lung autopsies provide a clearer picture of how SARS-CoV-2 virus spreads and causes damage

3D cell culturing platform allows study of idiopathic pulmonary fibrosis

Drug improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy

Discovery of new receptor that interacts with SARS-CoV-2 spike, suppresses infection

Updated mapping of the human genetic architecture of COVID-19

Your out-of-pocket health care costs need not be a mystery

Macrophages located in the cardiac tissue protect the failing heart

Study may pave the way for a more personalized approach to COVID-19 diagnosis and treatment

New treatment for myocardial infarction using mussel adhesive proteins

Platelet inhibitors may be linked with reduction in digital ulcers in people with systemic sclerosis

Hassenfeld Children's Hospital at NYU Langone performs first-ever pediatric lung transplant

Therapeutic heparin for preventing COVID-19 deaths is four times higher than the prophylactic dose

Pathway preferential estrogens may be a safer alternative to hormone replacement therapy, study shows

Five-day course of preoperative radiation therapy for sarcoma provides excellent local control rates

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News